3K3

5-({(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl}oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one

Created:	2014-08-28
Last modified:	2016-02-24

Find Related PDB Entry
1 entries where 3K3 is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	52
Chiral Atom Count	3
Bond Count	58
Aromatic Bond Count	22

2D diagram of 3K3

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-({(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl}oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one
Systematic Name (OpenEye OEToolkits)	5-[[(1R,1aS,6bR)-1-[5-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one
Formula	C₂₅ H₁₇ F₃ N₄ O₃
Molecular Weight	478.423
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	FC(F)(F)c1cc2nc(nc2cc1)C4C3c7c(OC34)ccc(Oc6ccnc5NC(=O)CCc56)c7
SMILES	CACTVS	3.385	FC(F)(F)c1ccc2[nH]c(nc2c1)[CH]3[CH]4Oc5ccc(Oc6ccnc7NC(=O)CCc67)cc5[CH]34
SMILES	OpenEye OEToolkits	1.7.6	c1cc2c(cc1C(F)(F)F)nc([nH]2)C3C4C3Oc5c4cc(cc5)Oc6ccnc7c6CCC(=O)N7
Canonical SMILES	CACTVS	3.385	FC(F)(F)c1ccc2[nH]c(nc2c1)[C@@H]3[C@H]4Oc5ccc(Oc6ccnc7NC(=O)CCc67)cc5[C@@H]34
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1cc2c(cc1C(F)(F)F)nc([nH]2)[C@H]3[C@H]4[C@@H]3Oc5c4cc(cc5)Oc6ccnc7c6CCC(=O)N7
InChI	InChI	1.03	InChI=1S/C25H17F3N4O3/c26-25(27,28)11-1-4-15-16(9-11)31-24(30-15)21-20-14-10-12(2-5-17(14)35-22(20)21)34-18-7-8-29-23-13(18)3-6-19(33)32-23/h1-2,4-5,7-10,20-22H,3,6H2,(H,30,31)(H,29,32,33)/t20-,21-,22-/m0/s1
InChIKey	InChI	1.03	NGFFVZQXSRKHBM-FKBYEOEOSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB14773
Name	Lifirafenib
Description	Lifirafenib is under investigation in clinical trial NCT03641586 (The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor).
Synonyms	Lifirafenib
Categories	Heterocyclic Compounds, Fused-Ring
CAS number	1446090-79-4

Related Resource References

Resource Name	Reference
Pharos	CHEMBL4209157
PubChem	89670174
ChEMBL	CHEMBL4209157

RCSB PDB is hosted by

RCSB PDB is a member of

RCSB Partners
Nucleic Acid Knowledgebase

CoreTrustSeal

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.